Iterum Therapeutics(ITRMF)
$0.030.00 (0.00%)
ITRMF
Iterum Therapeutics financials statements
$0.03
At close:0.00 (0.00%)
Want to see ITRMF full AI Analyst Report?
Iterum Therapeutics (ITRMF) Income Statement
951 Followers
Iterum Therapeutics Income Statement
Last quarter (Q3 2025), Iterum Therapeutics's total revenue was $390.00K. In Q3, Iterum Therapeutics's net income was $-8.98M. See Iterum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -254.00K | $ -1.75M | $ -1.80M | $ -2.10M | $ -161.00K | |
| $ 18.44M | $ 45.72M | $ 28.58M | $ 22.43M | $ 31.96M | |
| Depreciation and Amortization | $ 284.00K | $ 1.75M | $ 1.80M | $ 2.10M | $ 161.00K |
| $ -21.73M | $ -34.58M | $ -39.97M | $ -83.20M | $ -36.01M | |
| $ -18.70M | $ -47.47M | $ -30.38M | $ -24.54M | $ -32.13M | |
| $ -5.84M | $ 9.71M | $ -13.75M | $ -66.32M | $ -19.14M | |
| $ -24.53M | $ -37.76M | $ -44.13M | $ -90.86M | $ -51.26M | |
| $ -24.77M | $ -38.37M | $ -44.43M | $ -91.56M | $ -52.01M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.26 | $ -2.96 | $ -3.63 | $ -8.41 | $ -32.49 |
| Diluted EPS | $ -1.26 | $ -2.96 | $ -3.63 | $ -8.41 | $ -32.49 |
| Weighted Average Shares Outstanding | 19.70M | 12.96M | 12.24M | 10.89M | 24.01M |
| Weighted Average Shares Outstanding (Diluted) | 19.70M | 12.96M | 12.24M | 10.89M | 24.01M |
Currency in USD
